<em>The Lancet</em> Retracts Cardiac Stem Cell Clinical Trial Paper
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper
The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

The Lancet
Open-Access Plan in Europe Bans Publishing in Paywalled Journals
Open-Access Plan in Europe Bans Publishing in Paywalled Journals
Ashley Yeager | Sep 4, 2018
Research funding agencies in Europe will require grantees’ papers to be free to read when they are available online.
Longer Lives, More Disease
Longer Lives, More Disease
Dan Cossins | Dec 14, 2012
A comprehensive global health study finds that although life expectancy has increased in most countries, the burden of chronic disease is also on the rise.
Trouble at the CDC?
Bob Grant | Mar 12, 2012
Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.